NEW YORK — The following is a list of initial public offerings planned for the coming week.

500.com Ltd. – Shenzhen, China, 5.786 million American depositary shares, each representing 10 class A ordinary shares, priced $9 to $11, managed by Deutsche Bank. Proposed NYSE symbol WBAI. Business: Online sports lottery service provider.

GFI Software S.A. – Luxembourg, 6.1 million common shares, priced $12 to $14, managed by J.P. Morgan, Credit Suisse, and Jefferies. Proposed NYSE symbol GFIS. Business: Collaboration and IT software.

Navigator Holdings Ltd. – London, 11.3 million common shares, priced $17 to $19, managed by Jefferies, and Morgan Stanley. Proposed NYSE symbol NVGS. Business: Owns and operates the largest fleet of handysize liquefied gas carriers.

Oxford Immunotec Global plc – Abington, U.K., 5.36 million ordinary shares, priced $13 to $15, managed by J.P. Morgan, and Piper Jaffray. Proposed Nasdaq symbol OXFD. Business: Sells diagnostic tests for latent tuberculosis infection.

Sungy Mobile Ltd. – Guangzhou, China, 7 million American depositary shares, each representing 6 class A ordinary shares, priced $9.50 to $11.50, managed by Credit Suisse and J.P. Morgan. Proposed Nasdaq symbol GOMO. Business: Applications and mobile platform development.

Advertisement

TetraLogic Pharmaceuticals Corp. – Malvern, Pa., 6.43 million shares, priced $13 to $15, managed by Oppenheimer, Guggenheim, and Needham. Proposed Nasdaq symbol TLOG. Business: Small molecule therapeutics for the treatment of cancer.

Trevena Inc. – King of Prussia, Pa., 5.77 million shares, priced $12 to $14, managed by Barclays, and Jefferies. Proposed Nasdaq symbol TRVN. Business: Biotech developing treatments for acute heart failure.

Vince Holding Corp. – New York, 10 million shares, priced $17 to $19, managed by Goldman Sachs, Baird, and BofA Merrill Lynch. Proposed NYSE symbol VNCE. Business: High-end contemporary clothing line.

Vital Therapies Inc. – San Diego, 4.4 million shares, priced $16 to 418, managed by Credit Suisse, and William Blair. Proposed Nasdaq symbol VTL. Business: Biotech developing treatments for acute liver failure.


Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.